当前位置:首页 - 行情中心 - 泓博医药(301230) - 财务分析

泓博医药

(301230)

  

流通市值:29.01亿  总市值:52.69亿
流通股本:7686.03万   总股本:1.40亿

泓博医药(301230)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润0.25亿元,每股收益0.18元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益106016.36万元,未分配利润17423.68万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产135658.59万元,负债29642.23万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入352,738,072.83169,429,129.41544,471,262.04391,402,290.83
营业总成本329,746,732.17157,965,262.18553,727,749.83396,611,989.68
其他经营收益
营业利润22,744,651.5311,119,439.093,633,016.26,433,317.12
利润总额22,677,172.9111,059,785.943,535,116.376,465,187.15
净利润24,761,426.2711,973,873.8217,083,154.8315,243,605.85
每股收益
其他综合收益-112,334.74-81,158.6964,923.15-4,824.99
综合收益总额24,649,091.5311,892,715.1317,148,077.9815,238,780.86
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计618,934,271.92584,490,479.58554,317,975.45620,478,092.95
非流动资产:
非流动资产合计737,651,658.01746,779,546762,108,412.74737,683,056.6
资产总计1,356,585,929.931,331,270,025.581,316,426,388.191,358,161,149.55
流动负债:
流动负债合计149,623,885.8134,091,501.45125,397,520.57150,656,447.31
非流动负债:
非流动负债合计146,798,435.93150,934,307.26158,331,409.82162,956,894.05
负债合计296,422,321.73285,025,808.71283,728,930.39313,613,341.36
所有者权益(或股东权益):
归属于母公司股东权益合计1,060,163,608.21,046,244,216.871,032,697,457.81,044,547,808.19
股东权益合计1,060,163,608.21,046,244,216.871,032,697,457.81,044,547,808.19
负债和股东权益合计1,356,585,929.931,331,270,025.581,316,426,388.191,358,161,149.55
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计281,252,796.67128,078,776.98539,351,247.7387,357,197.61
经营活动现金流出小计241,826,667.93129,955,084.88458,487,717.95366,250,165.13
经营活动产生的现金流量净额39,426,128.74-1,876,307.980,863,529.7521,107,032.48
投资活动产生的现金流量:
投资活动现金流入小计20,105,380.5310,059,178.08622,973,363.97597,246,631.55
投资活动现金流出小计27,276,315.216,339,135.58667,795,592.82590,153,655.98
投资活动产生的现金流量净额-7,170,934.67-6,279,957.5-44,822,228.857,092,975.57
筹资活动产生的现金流量:
筹资活动现金流入小计20,664,755.587,653,171.3419,654,670.8919,654,670.89
筹资活动现金流出小计23,924,858.96,321,483.55157,260,798.68130,641,879.54
筹资活动产生的现金流量净额-3,260,103.321,331,687.79-137,606,127.79-110,987,208.65
汇率变动对现金及现金等价物的影响2,110,7281,322,735.544,816,818.382,791,150.46
现金及现金等价物净增加额31,105,818.75-5,501,842.07-96,748,008.51-79,996,050.14
期末现金及现金等价物余额69,854,765.9233,247,105.138,748,947.1755,500,905.54
补充资料:
现金及现金等价物的净增加额31,105,818.75--96,748,008.51-
最新报告期:2025-09-02
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
开源证券汪晋,余汝意0.430.590.822025-09-02
太平洋周豫,张崴0.430.621.002025-08-28
太平洋周豫,张崴0.330.460.712025-07-15
TOP↑